MicroRNA profiles of drug-resistant myeloma cell lines

Acta Haematologica

Volumn 123, Issue 4, 2010, Pages 201-204

  Munker, Reinhold ^a   Liu, Chang Gong ^b   Taccioli, Cristian ^b   Alder, Hansjuerg ^b   Heerema, Nyla ^c  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b Department of Molecular Virology Immunology and Human Genetics   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MELPHALAN; MICRORNA;

ARTICLE; CANCER CELL CULTURE; CELL SUSPENSION; CONTROLLED STUDY; CYTOGENETICS; GENE OVEREXPRESSION; GENETIC SCREENING; HUMAN; HUMAN CELL; KARYOTYPING; METAPHASE; MICROARRAY ANALYSIS; MYELOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MULTIPLE MYELOMA; RNA, NEOPLASM;

EID: 77950028002     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000302889     Document Type: Article

References (11)

1. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nature Rev Cancer 2006; 6: 857-866.
2. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Aqeilan RI, Croce CM: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 2008; 105: 12885-12890.
3. Bao F, Polk P, Nordberg ML, Veillon DM, Sun A, Deininger M, Murray D, Andersson BS, Munker R: Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res 2007; 31: 1511-1520.
4. Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM: Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res 1991; 51: 995-1002.
5. Shaffer LG, Tommerup N (eds): ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Karger, 2005.
6. Liu CG, Spizzo R, Calin GA, Croce CM: Expression profiling of microRNA using oligo DNA arrays. Methods 2008; 44: 22-30.
7. Mimeault M, Hauke R, Batra SK: Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther 2008; 83: 673-691.
8. Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, Saporta S, Boulware D, Moscinski L, Alsina M, Dalton WSl: Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 2003; 63: 7000-7006.
9. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C: Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008; 111: 478-486.
10. Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 2008; 27: 3845-3855.
11. Chen GQ, Zhao ZW, Zhou HY, Liu YJ, Yang HJ: Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin. Med Oncol 2009; E-pub May 2009.